Novomix 30 Insulin Flexpen - 3ml
Novomix 30 Insulin Flexpen - 3ml
Product Description:
Novomix 30 Insulin Flexpen is a modern insulin analogue designed for the management of diabetes mellitus in adults, adolescents, and children aged 10 years or above. This premixed insulin formulation combines rapid-acting insulin aspart with intermediate-acting protamine-crystallized insulin aspart, offering both prandial and basal insulin coverage in a single injection. The Flexpen technology provides a convenient and discreet option for insulin administration, ensuring accurate dosing and enhanced patient compliance.
Technical Specifications:
- Volume: 3ml per Flexpen
- Concentration: 100 units/ml (U-100)
- Insulin Composition: 30% soluble insulin aspart, 70% protamine-crystallized insulin aspart
- Dosing: Adjustable in 1-unit increments
- Storage: Refrigerated (2-8°C) before first use, room temperature (up to 30°C) after first use
- Shelf Life: 4 weeks at room temperature after first use
- Compatibility: For subcutaneous injection; use with NovoFine or NovoTwist disposable needles
Common Applications/User Groups:
Novomix 30 is commonly prescribed for:
- Adults with type 2 diabetes mellitus requiring insulin for glycemic control
- Adolescents and children aged 10 years or older with type 1 diabetes mellitus
- Patients seeking a convenient and portable insulin delivery system
- Individuals requiring a premixed insulin to simplify the dosing regimen
Supplier Overview:
Novo Nordisk is a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This heritage has given them the experience and capabilities that also enable them to help people defeat other serious chronic conditions such as haemophilia, growth disorders and obesity. Novo Nordisk is renowned for their advanced products in the biopharmaceutical industry, particularly in insulin and diabetes care, making them a trusted authority in the field. Their commitment to improving patient outcomes and their continuous investment in research and development solidify their position as a leading supplier of diabetes care solutions, including the Novomix 30 Insulin Flexpen.
Original: $32.89
-65%$32.89
$11.51Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Novomix 30 Insulin Flexpen - 3ml
Product Description:
Novomix 30 Insulin Flexpen is a modern insulin analogue designed for the management of diabetes mellitus in adults, adolescents, and children aged 10 years or above. This premixed insulin formulation combines rapid-acting insulin aspart with intermediate-acting protamine-crystallized insulin aspart, offering both prandial and basal insulin coverage in a single injection. The Flexpen technology provides a convenient and discreet option for insulin administration, ensuring accurate dosing and enhanced patient compliance.
Technical Specifications:
- Volume: 3ml per Flexpen
- Concentration: 100 units/ml (U-100)
- Insulin Composition: 30% soluble insulin aspart, 70% protamine-crystallized insulin aspart
- Dosing: Adjustable in 1-unit increments
- Storage: Refrigerated (2-8°C) before first use, room temperature (up to 30°C) after first use
- Shelf Life: 4 weeks at room temperature after first use
- Compatibility: For subcutaneous injection; use with NovoFine or NovoTwist disposable needles
Common Applications/User Groups:
Novomix 30 is commonly prescribed for:
- Adults with type 2 diabetes mellitus requiring insulin for glycemic control
- Adolescents and children aged 10 years or older with type 1 diabetes mellitus
- Patients seeking a convenient and portable insulin delivery system
- Individuals requiring a premixed insulin to simplify the dosing regimen
Supplier Overview:
Novo Nordisk is a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This heritage has given them the experience and capabilities that also enable them to help people defeat other serious chronic conditions such as haemophilia, growth disorders and obesity. Novo Nordisk is renowned for their advanced products in the biopharmaceutical industry, particularly in insulin and diabetes care, making them a trusted authority in the field. Their commitment to improving patient outcomes and their continuous investment in research and development solidify their position as a leading supplier of diabetes care solutions, including the Novomix 30 Insulin Flexpen.
